Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
01 1Transo-Pharm Handels GmbH
02 1Malladi Drugs & Pharmaceuticals Limited
03 1EUROAPI
04 1Transo-Pharm USA LLC
05 13M Company
06 1Amphastar Pharmaceuticals
07 1Boehringer Ingelheim GmbH
08 1Cambrex Corporation
09 2Curia
10 1Derivados Quimicos SAU
11 2GLAND PHARMA LIMITED
12 1Guangzhou Tosun Pharmaceutical
13 1Hunan Warrant Chiral Pharmaceutical
14 1Medinex Laboratories
15 1Shenzhen Oriental Pharmaceutical
16 1Sichuan Renan Pharmaceutical
17 1Sun Pharmaceutical Industries Limited
18 1Syn-Tech Chem. & Pharm
19 1Tianish Laboratories
20 1Viatris
21 1Wockhardt
22 2Wuhan Wuyao Pharmaceutical
01 6China
02 1France
03 2Germany
04 7India
05 1Spain
06 1Taiwan
07 7U.S.A
01 11Active
02 2Inactive
03 12Blank
01 4Valid
02 1Withdrawn by Holder
03 20Blank
01 1218MF10483
02 1226MF10196
03 1230MF10047
04 22Blank
01 1TFDA-00021
02 1WC-0075a3
03 1WC-0168
04 22Blank
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-01-11
Pay. Date : 2016-12-28
DMF Number : 30997
Submission : 2016-09-20
Status : Active
Type : II
Certificate Number : R1-CEP 2016-232 - Rev 00
Issue Date : 2023-02-09
Type : Chemical
Substance Number : 2303
Status : Valid
Date of Issue : 2018-07-04
Valid Till : 2022-01-15
Written Confirmation Number : TFDA-00021
Address of the Firm :
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25874
Submission : 2012-03-12
Status : Active
Type : II
NDC Package Code : 59349-0019
Start Marketing Date : 2018-11-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21213
Submission : 2007-12-31
Status : Active
Type : II
Date of Issue : 2020-10-16
Valid Till : 2022-07-21
Written Confirmation Number : WC-0075a3
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-05
Pay. Date : 2021-12-30
DMF Number : 28617
Submission : 2014-09-18
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-06-09
Pay. Date : 2021-04-30
DMF Number : 35384
Submission : 2020-12-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-12-05
Pay. Date : 2023-09-29
DMF Number : 38733
Submission : 2023-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28749
Submission : 2014-12-10
Status : Active
Type : II
NDC Package Code : 65015-846
Start Marketing Date : 2015-02-18
End Marketing Date : 2026-12-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
We have 22 companies offering Racepinephrine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?